Real-time enrollment status for this end stage kidney disease clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 3:50 PM UTC
| NCT Number | NCT05485961 |
| Recruiting Status | Recruiting |
| Condition | End Stage Kidney Disease |
| Phase | PHASE2 |
| Target Enrollment | 3,110 participants |
| Active Locations | 167 sites in the US |
| Sponsor | CSL Behring |
| Last Updated on CT.gov | September 21, 2026 (3 weeks ago) |
As of October 16, 2026: Clinical trial NCT05485961 is currently recruiting participants. This phase2 study for end stage kidney disease is actively seeking new participants at 167 locations across the United States. The study is sponsored by CSL Behring. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05485961 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 167 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05485961 was last updated 3 weeks ago (September 21, 2026). HelloStudys verifies this status automatically.